Marilyn Fontaine

Marilyn joins us with over 12 years of pharmaceutical development experience focusing small oncology company settings.  Her career started as a Clinical Trial Associate at Sumitomo Pharma Oncology (formerly Boston Biomedical). In her time there, she led a global phase 3 study, managed the TMF department, and supported multiple studies at the program level.  She spent some time at Black Diamond Therapeutics developing process and training for the Clinical Operations department. She is currently Director of Clinical Operations at Compass Therapeutics, where she leads a program with an ongoing phase 2 and phase 2/3 study. Marilyn holds a BS in Anatomy and Cell Biology from McGill University.